Substance / Medication

Belladonna alkaloid

Overview

Active Ingredient
belladonna alkaloids
RxNorm CUI
1359

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

19 trials linked to this intervention

19
Total Trials
7
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
A systematic review of yoga for the treatment of gastrointestinal disorders.
Thakur Elyse R, Shapiro Jordan M, Wellington Jennifer et al. · Neurogastroenterol Motil · 2026
PMID: 39285826Meta-Analysis
Gastrointestinal Dysautonomia After Immune Checkpoint Inhibitor Therapy: A Case Series and Systematic Review.
Sennfält S, Norton B, Jarjis A T et al. · Neurogastroenterol Motil · 2026
PMID: 41319158Meta-Analysis
Wearable-Based Monitoring of Autonomic and Gastrointestinal Function in Disorders of Gut-Brain Interaction: A Systematic Review and Meta-Analyses.
Veldman Fleur, Bosman Michelle, Rezaie Ali et al. · Neurogastroenterol Motil · 2026
PMID: 41553708Meta-AnalysisFull text (PMC)
A systematic review of preclinical studies targeted toward the management of co-existing functional gastrointestinal disorders, stress, and gut dysbiosis.
Pal Shreyashi, Arisha Ruhi, Mazumder Papiya Mitra · Naunyn Schmiedebergs Arch Pharmacol · 2025
PMID: 39096376Meta-Analysis
Diagnosis and Management of Thoracolumbar Spinal Disorders Presenting as Cardiac, Gastrointestinal, and Other False Pain Syndromes.
Brown Nolan J, Kuo Cathleen, Pennington Zach et al. · Clin Spine Surg · 2025
PMID: 39450872Meta-Analysis
Systematic Review and Meta-Analysis: Examining the Psychometric Evaluations of Disordered Eating Scales in Adults Living With Gastrointestinal Conditions.
Soliman Olivia Marie, Mikocka-Walus Antonina, Warner Molly M et al. · Neurogastroenterol Motil · 2025
PMID: 39928514Meta-AnalysisFull text (PMC)
Indications and endoscopic findings of upper gastrointestinal diseases in Africa: A systematic review & meta-analysis.
Abdu Seid Mohammed, Assefa Ebrahim Msaye, Abdu Hussen · PLoS One · 2025
PMID: 40080520Meta-AnalysisFull text (PMC)
Dietary essential oil components: A systematic review of preclinical studies on the management of gastrointestinal diseases.
Gopalsamy Rajiv Gandhi, Antony Poovathumkal James, Athesh Kumaraswamy et al. · Phytomedicine · 2025
PMID: 40085990Meta-Analysis
Learning deficits induced by 4 belladonna alkaloids are preferentially attenuated by tacrine.
Pan S Y, Han Y F · Acta Pharmacol Sin · 2000
PMID: 11263258Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Belladonna alkaloid (substance)
SNOMED CT
391816007
UMLS CUI
C0004954
RxNorm CUI
1359

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
19
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.